"Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention" was originally created and published by ...

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Health and resource organizations will host free testing events across locations in Dallas on Friday for National HIV Testing ...